Botwood Nicholas A.J.
SEC insider (Form 3/4/5 filer). CIK 0002066784. Head of R&D, CMO at Syndax Pharmaceuticals Inc (SNDX). 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 12, 2026. Located in NEW YORK, NY.
Companies Botwood Nicholas A.J. has filed insider reports for
- Syndax Pharmaceuticals Inc (SNDX): Officer, Head of R&D, CMO
Botwood Nicholas A.J.
CIK: 0002066784
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Syndax Pharmaceuticals Inc
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 12, 2026SNDX
Syndax Pharmaceuticals Inc
SaleDirect31.2K shares at avg. $18.14$567K - Jun 12, 2026SNDX
Syndax Pharmaceuticals Inc
ExerciseDirect31.2K shares at avg. $13.82$432K - Jun 11, 2026SNDX
Syndax Pharmaceuticals Inc
ExerciseDirect22.5K shares at avg. $13.82$311K - Jun 11, 2026SNDX
Syndax Pharmaceuticals Inc
SaleDirect34.3K shares at avg. $18.00$617K - Feb 4, 2026SNDX
Syndax Pharmaceuticals Inc
AwardDirect36K shares- - Feb 4, 2026SNDX
Syndax Pharmaceuticals Inc
AwardDirect24K shares- - May 16, 2025SNDX
Syndax Pharmaceuticals Inc
PurchaseDirect11.8K shares at avg. $8.99$106K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 12, 2026 | SNDX Syndax Pharmaceuticals Inc | Sale | 31,235 | $18.14 | $566,603 | Direct |
| Jun 12, 2026 | SNDX Syndax Pharmaceuticals Inc | Exercise | 31,235 | $13.82 | $431,668 | Direct |
| Jun 11, 2026 | SNDX Syndax Pharmaceuticals Inc | Exercise | 22,515 | $13.82 | $311,157 | Direct |
| Jun 11, 2026 | SNDX Syndax Pharmaceuticals Inc | Sale | 34,280 | $18.00 | $617,040 | Direct |
| Feb 4, 2026 | SNDX Syndax Pharmaceuticals Inc | Award | 36,000 | - | $0 | Direct |
| Feb 4, 2026 | SNDX Syndax Pharmaceuticals Inc | Award | 24,000 | - | $0 | Direct |
| May 16, 2025 | SNDX Syndax Pharmaceuticals Inc | Purchase | 11,765 | $8.99 | $105,826 | Direct |
1-7 of 7 transactions